CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial. (nature.com)

Authors: Albach FN … Kronke G Journal: Nature Medicine Published: 2026-08-27 DOI: https://doi.org/10.1038/s41591-026-04603-3